Piper Sandler Trims Aptose Biosciences (NASDAQ:APTO) Target Price to $5.00
Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) had its target price cut by Piper Sandler from $12.00 to $5.00 in a research note released on Thursday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Several other research analysts have also commented on the stock. StockNews.com raised shares of Aptose […]
More Stories
Target Co. (NYSE:TGT) Shares Sold by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. reduced its holdings in Target Co. (NYSE:TGT – Free Report) by 4.1% during the 3rd...
Prospera Private Wealth LLC Invests $5.27 Million in Mastercard Incorporated (NYSE:MA)
Prospera Private Wealth LLC purchased a new position in Mastercard Incorporated (NYSE:MA – Free Report) during the 3rd quarter, according...
Lowe’s Companies, Inc. (NYSE:LOW) Holdings Lowered by Commerce Bank
Commerce Bank lessened its stake in shares of Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 0.0% during the 3rd...
Hilton Capital Management LLC Increases Stock Holdings in Eli Lilly and Company (NYSE:LLY)
Hilton Capital Management LLC raised its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.5% during the...
Advisors Asset Management Inc. Trims Stock Position in Automatic Data Processing, Inc. (NASDAQ:ADP)
Advisors Asset Management Inc. trimmed its stake in shares of Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report) by 3.9%...
MTM Investment Management LLC Takes Position in NextEra Energy, Inc. (NYSE:NEE)
MTM Investment Management LLC acquired a new position in shares of NextEra Energy, Inc. (NYSE:NEE – Free Report) during the...